MICROFUE HAIR RESTORATION SURGERY

The micro FUE method is the use of thin needles (with a diameter of between 0.6-0.8mm) and a micro motor. The healthy follicular units found on the nape and the side areas of the head are targeted. The targeted units are removed one by one without causing harm using thin, hollow needles with a diameter of between 0.6-0.8 mm attached to a micro motor. Thanks to grafts with smaller volume collected with thin needles, natural looking hair transplants that are as dense as desired can be done. In order to place the grafts, some doctors make very small incisions with a sharp instrument and insert the grafts into these incisions by holding them with fine tip instruments.

As a result of micro FUE method, the regeneration of the skin is very fast ( the grafts regenerate in 7 days and the donor in 2 days ) and the final result is highly esthetic and natural.

Since a very natural look can be achieved with the micro FUE technique, results are very successful not only in hair transplantation, but also in beard, moustache, eyebrow and eyelash implants and in more eye-catching places like wound and burn scars.

Hair restoration is a highly sophisticated subspecialty that offers significant relief to patients with hair loss. An improved understanding of the aesthetics of hair loss and cosmetic hair restoration, hair anatomy and physiology, and the development of microvascular surgical instrumentation has revolutionized the approach to surgical hair restoration since the original description. Additional elements that contribute to the current state of the art in hair restoration include graft size, site creation, packing density, and medical control of hair loss.

The results of hair restoration are natural in appearance and are provided with a very high level of patient satisfaction and safety. This aspect of cosmetic surgery is a very welcome addition to a traditional aesthetic practice and serves as a tremendous source for internal cross-referral. The future of hair restoration surgery is centered on minimal-incision surgery as well as cell-based therapies.